ENDRA Life Sciences Inc. announced impairment charges for the first quarter ended March 31, 2024. For the period, the company announced fixed assets write off of $8,808.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.1097 USD | -2.05% | +29.06% | -94.83% |
Jun. 04 | Sector Update: Health Care Stocks Rise Late Afternoon | MT |
Jun. 04 | Top Midday Decliners | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-94.83% | 1.92M | |
+49.21% | 56.95B | |
+39.98% | 40.26B | |
-6.86% | 39.32B | |
-4.42% | 28.37B | |
+12.00% | 26.45B | |
-18.27% | 19.41B | |
+29.57% | 12.54B | |
+25.41% | 12.21B | |
-0.35% | 12.15B |
- Stock Market
- Equities
- NDRA Stock
- News ENDRA Life Sciences Inc.
- Endra Life Sciences Inc. Announces Impairment Charges for the First Quarter Ended March 31, 2024